A carregar...
Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
BACKGROUND: The development of heart failure is accompanied by complex changes in cardiac electrophysiology and functional properties of cardiomyocytes and fibroblasts. Histone deacetylase (HDAC) inhibitors hold great promise for the pharmaceutical therapy of several malignant diseases. Here, we des...
Na minha lista:
| Publicado no: | BMC Pharmacol Toxicol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6404297/ https://ncbi.nlm.nih.gov/pubmed/30841920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-019-0294-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|